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Background & aims: This post hoc study aimed to determine whether major elective abdominal surgery
had any acute impact on mitochondrial pyruvate dehydrogenase complex (PDC) activity and maximal
mitochondrial ATP production rates (MAPR) in a large muscle group (vastus lateralis -VL) distant to the
site of surgical trauma.
Methods: Fifteen patients undergoing major elective open abdominal surgery were studied. Muscle bi-
opsies were obtained after the induction of anesthesia from the VL immediately before and after surgery
for the determination of PDC and maximal MAPR (utilizing a variety of energy substrates).
Results: Muscle PDC activity was reduced by >50% at the end of surgery compared with pre-surgery
(p < 0.05). Muscle MAPR were comprehensively suppressed by surgery for the substrate combina-
tions: glutamate þ succinate; glutamate þ malate; palmitoylcarnitine þ malate; and pyruvate þ malate
(all p < 0.05), and could not be explained by a lower mitochondrial yield.
Conclusions: PDC activity and mitochondrial ATP production capacity were acutely impaired in muscle
distant to the site of surgical trauma. In keeping with the limited data available, we surmise these events
resulted from the general anesthesia procedures employed and the surgery related trauma. These
findings further the understanding of the acute dysregulation of mitochondrial function in muscle
distant to the site of major surgical trauma in patients, and point to the combination of general anes-
thesia and trauma related inflammation as being drivers of muscle metabolic insult that warrants further
investigation.
Clinical trial registration: Registered at (NCT01134809).
© 2020 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license
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Whole-body insulin resistance accompanies surgical trauma,
and appears to be proportional to the magnitude of injury incurred
[1]. Skeletal muscle is the primary site for insulin-dependent
glucose uptake, and surgical trauma appears to play an important
role in the downregulation of muscle glucose uptake and oxidation
following major abdominal surgery in patients [2] and animal
models [3] that includes inhibition of mitochondrial pyruvate de-
hydrogenase complex (PDC) activation via upregulation of pyruvate
dehydrogenase kinase 4 isoform (PDK4) [4].
The mitochondrion is primarily responsible for generating >90%
of the cellular energy supply, in the form of adenosine triphosphate
(ATP). It is versatile in its ability to do this by utilizing severalle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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the primary fuels. The PDC, is a multi-enzyme complex located on
the inner mitochondrial membrane. It controls the irreversible
conversion of pyruvate to mitochondrial acetyl-CoA, the rate
limiting step in carbohydrate oxidation, and is downregulated in
skeletal muscle within 2 h of the onset of in vivo endotoxemia in an
animal model [5], and within 6e8 h of admission of patients to the
intensive care unit [6]. Furthermore, several inflammatory media-
tors, including cytokines, have been reported to induce mitochon-
drial dysfunction in vitro via changes in the activity of
mitochondrial enzyme complexes and the mitochondrial mem-
brane potential, and consequently rates of ATP formation [7e10]. In
short, therefore, inflammation-mediated impairment of PDC and
mitochondrial function play an important role in the acute dysre-
gulation of muscle metabolism in inflammatory conditions. More-
over, mitochondria isolated the second day following surgical
trauma in pigs were reported to exhibit diminished ADP stimulated
respiration for pyruvate [3], although the relevance of this post-
surgical response to the acute human surgical condition remains
unclear.
As outlined above, we have shown that major abdominal sur-
gery acutely resulted in marked inflammation (TNF-a and IL-6) and
molecular (MAFbx, cathepsin-L, FOXO1, PDK4) and metabolic
(glycogen and lactate content) dysregulation predictive of
increased muscle protein degradation and impaired carbohydrate
oxidation in the rectus abdominis muscle local to the site of surgical
trauma [2]. However, whilst these local responses weremirrored by
a similar, albeit blunted, mRNA expression response in the vastus
lateralis (VL) muscle distant to the site of injury, significant changes
in muscle glycogen and lactate contents and proteins regulating
muscle inflammation, protein breakdown and carbohydrate
oxidation were not evident in this muscle [2]. This suggests muscle
energy homeostasis was not overtly compromised distant to the
site of surgery, at least acutely. On the other hand, human cell
culture and animal research have demonstrated that general an-
esthetics can profoundly impair mitochondrial function in a num-
ber of organs [11e17]. Furthermore, the limited human research
available corroborates this. For example, skeletal muscle mito-
chondrial respiration was impaired in patients during general
anesthesia for hip prosthesis placement or femoral fracture repair
compared with the same procedures being performed under
regional anesthesia [18]. The extent to which this impairment of
muscle mitochondrial function during general anesthesia was
attributable to surgical trauma-related inflammation, general
anesthesia or the combination of both is, however, unknown.
This aim of this post hoc study, therefore, was to determine
whether major elective abdominal surgery had any acute negative
impact on PDC activity andmitochondrial function in the VLmuscle
distant to the site of surgical trauma.
2. Methods
This study comprised a post hoc consideration of data generated
from VL muscle samples previously collected and analysed [2].
With the exception of VL muscle mRNA measurements of the cy-
tokines interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF-
a) [2], all data presented in this manuscript are unpublished [i.e.
muscle pyruvate dehydrogenase complex activity, citrate synthase
activity and maximal mitochondrial ATP production rates (MAPR, 5
substrate mixtures) pre- and post-surgery].
Fifteen adult participants (mean age ± SEM, 49.0 ± 4.5 years,
body mass index 26.0 ± 1.7 kg/m2, 13 males) undergoing major
elective open abdominal surgery were studied, following UK na-
tional research ethics service approval and informed written con-
sent. Seven of these patients were operated for pancreatic cancerand eight were for benign disease, such as chronic pancreatitis and
incisional herniae. The protocol was registered at ClinicalTrials.gov
(NCT01134809). Exclusion criteria included emergency surgery,
liver surgery, chronic illness (e.g. diabetes mellitus), disseminated
malignant disease, and medications known to affect glucose
metabolism, statins, and chronic use of antibiotics, anti-
inflammatory drugs, or immunosuppressive agents.
At the start and end of abdominal surgery, a biopsy was ob-
tained from the VL muscle, using a percutaneous conchotome
technique. The pre-surgery sample was collected 45e65 min after
the start of induction of anesthesia, but prior to commencement of
the operation, and the post-surgery sample was obtained from the
contralateral limb at the end of the operation to avoid any impact of
local tissue injury from the pre-surgery biopsy. In order to assay
mitochondrial function, mitochondria were immediately isolated
from a portion of muscle tissue and re-suspended in working
buffers immediately after biopsy sampling (further details below).
The immediacy of the procedure reflects the necessity to maintain
the mitochondrial double membrane structure and its viability,
which is crucial when assessing MAPR. The remaining piece of
muscle was immediately frozen in liquid nitrogen.
2.1. Muscle IL-6 and TNF-a mRNA
Total RNA was extracted from approximately 25 mg of wet
muscle using Tri Reagent (Ambion, Fisher Scientific, Loughborough,
UK), and quantified spectrophotometrically at 260 nm, with RNA
purity being determined as the ratio of 260/280 nm readings.
Thereafter, first strand cDNA synthesis was carried out, and mRNA
expression levels of IL-6 and TNF-alpha were determined using
TaqMan PCR (ABI prism 7900 HT sequence detector, Applied Bio-
systems, Warrington, UK), as described previously [2].
2.2. Muscle pyruvate dehydrogenase complex activity
A portion of frozen wet muscle (5e10 mg) was used to measure
PDC in its dephosphorylated (active) form (PDCa), as described
previously [19]. Briefly, muscles were homogenized in a buffer
containing NaF and dichloroacetate (DCA), and the activity of PDC
in its dephosphorylated (active) form was measured as a rate of
acetyl-CoA formation (mmol/min/kg wet muscle) at 37 C. Acetyl-
CoA was determined as [14C]citrate after condensation with [14C]-
oxaloacetate by citrate synthase.
2.3. Muscle maximal mitochondrial ATP production rates
Following removal of the biopsy sample from the thigh,
approximately 40 mg of muscle tissue (retained on ice) was
immediately diced finely on a cooled glass plate and weighed in mg
to an accuracy of two decimal places (Mettler Toledo scales, model
XS105, Leicester, UK). The diced muscle was then homogenized for
3 min on ice, using a Teflon pestle homogenizer and a glass ho-
mogenization vessel (Camlab Homogeniser, model K43, Camlab
Ltd., Cambridge, UK), in homogenization buffer [pH 7.2, KCl
100 mM, KH2PO4 50 mM, Tris 50 mM, MgCl2 5 mM, EDTA 1 mM,
ATP 1.8 mM (all from Sigma Aldrich, Gillingham, UK)]. The crude
homogenate was centrifuged at 650 g for 3 min, at 4 C (Hettich
Refrigerated Centrifuge, model EBA12R, DJB Labcare Ltd., Newport
Pagnell, UK). The resultant supernatant was transferred to a clean
test tube and centrifuged at 15,000 g for 3 min, at 4 C. Following
this, the supernatant was removed and discarded before resus-
pending the mitochondria-rich pellet in the original homogeniza-
tion buffer. This was then centrifuged at 15,000 g for 3 min, at 4 C.
After removal of the supernatant, the pellet was resuspended in a
resuspension solution (pH 7.2, human serum albumin 0.5 mg/ml,
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acetate tetrahydrate 2 mM, EDTA 0.5 mM). The mitochondrial
suspension was then retained on ice prior to assessing MAPR, or
was frozen at 80 C for analysis of citrate synthase activity at a
later date (see below).
MAPR were determined on the mitochondrial suspension under
optimal conditions utilizing a mixture of substrates
(glutamate þ succinate, glutamate þ malate,
palmitoylcarnitine þ malate, pyruvate þ malate, and succinate)
employing a bioluminescence based technique as described pre-
viously [20], with the increase in luminescence due to the pro-
duction of ATP being measured. Briefly, isolated mitochondria were
introduced to a luciferase-based monitoring reagent (BioTherma,
Handen, Sweden), along with ATP-free adenosine diphosphate
(ADP 18 mM) and a predetermined mitochondrial substrate
mixture (e.g. pyruvate þ malate), and the rate of increase in lumi-
nescence due to the production of ATP was recorded. Typically,
isolated muscle mitochondria were retained on ice, 12 cuvettes
were employed each containing of 800 ml luciferase based ATP
production monitoring reagent (lyophilised ATP monitoring re-
agent, BioTherma, Sweden), containing firefly luciferase, D-lucifer-
ine 0.1 g/L, L-luciferine 4 mg/L, bovine serum albumin 1 g/L, and
Na2P2O7 1 mM) dissolved in (sucrose 0.19 M, monopotassium
phosphate 19 mM, magnesium acetate tetrahydrate 2.5 mM, EDTA
0.7 mM pH 7), 140 ml of a substrate mixture (see above), 50 ml
0.6 mM ADP (Sigma Aldrich, UK), and (added last) 10 ml of diluted
mitochondrial suspension (1:100) in the same resuspension buffer.
The cuvettes were then transferred to the luminometer (BioOrbit
1253 Luminometer, Turku, Finland) to quantify luminescence (mV)
over time. As luminescence is directly a result of the ATP content,
luminescence steadily increased as ATP was being produced by the
active and intact, isolated respiring mitochondria. After 3e5 min,
cuvettes were injectedwith 3 ml of 50 mMATP standard, triggering a
sudden increase (spike) in luminescence, which was allowed to
continue for a fewmore minutes before the recording was stopped.
The addition of the ATP standard allowed the internal conversion of
the relative mitochondrial activity (mV/min) into absolute rates
(mM ATP/min).
This highly sensitive method measures mitochondrial ATP pro-
duction directly, and unlike classical respirometry is not affected
negatively by mitochondrial uncoupling, where mitochondrial ATP
production extrapolated from the measurement of oxygen con-
sumption can be prone to overestimation. Therefore, direct mea-
surement of mitochondrial ATP production provides a novel and
valuable insight.2.4. Muscle citrate synthase activity
Muscle citrate synthase activity was measured spectrophoto-
metrically on each frozen aliquot of muscle mitochondrial sus-
pension as described previously [21] and was used to normalize
MAPR to mitochondrial content, i.e. determination of intrinsic
MAPR.Fig. 1. Muscle pyruvate dehydrogenase complex (PDC) activity in vastus lateralis
muscle pre and post major abdominal surgery. Values represent mean ± SEM and
individual values. Difference between pre and post-surgery: *p < 0.05.2.5. Statistical analysis
All data are expressed as mean ± SEM. Differences between pre-
and post-surgery muscle measurements were determined using
the Student t-test for paired samples (for parametric data) and
related samples Wilcoxon Signed Ranks Test (for non-parametric
data). Differences were considered significant at p < 0.05.3. Results
The mean ± SEM time elapsed between the start and the end of
surgery was 223 ± 22 min (range 110e390 min).
3.1. Muscle IL-6 and TNF-a mRNA
Following surgery, VL muscle IL-6 and TNF-a mRNA were
increased 126-fold (p < 0.05) and 5.8-fold (p < 0.05), respectively,
compared with the pre-surgery expression levels [2].
3.2. Muscle citrate synthase activity
There was no difference in muscle citrate synthase activity from
pre- to post-surgery (2.05 ± 0.23 vs 1.67 ± 0.33 nmol/min/ml
mitochondrial suspension, respectively, p ¼ 0.393), indicating
mitochondrial density was no different between sampling time
points.
3.3. Muscle pyruvate dehydrogenase complex activity
Muscle PDC activity was reduced >50% at the end of surgery
compared with pre-surgery (Fig. 1, p < 0.05).
Table 1 demonstrates there was no difference in muscle PDC
activity when comparing patients with pancreatic cancer and pa-
tients with benign disease either pre- or post-surgery.
3.4. Muscle maximal mitochondrial ATP production rates
Mitochondrial ATP production rates declined by ~40% from pre-
to post-surgery when glutamate þ succinate, glutamate þ malate,
Table 1
Maximal mitochondrial ATP production rates and pyruvate dehydrogenase complex activity in vastus lateralis muscle pre and post major abdominal surgery in patients with




Glutamate þ succinate Glutamate þ malate Palmitoylcarnitine þ malate Pyruvate þ malate Succinate
Pre-surgery
Patients with cancer 0.51 ± 0.06 1.16 ± 0.12 0.77 ± 0.11 0.52 ± 0.06 0.43 ± 0.03 0.12 ± 0.03
Patients with benign
disease
0.66 ± 0.09 0.82 ± 0.09*** 0.69 ± 0.06 0.42 ± 0.05 0.38 ± 0.06 0.19 ± 0.05
Post-surgery
Patients with cancer 0.22 ± 0.02 0.76 ± 0.09 0.43 ± 0.07 0.33 ± 0.04 0.26 ± 0.03 0.12 ± 0.04
Patients with benign
disease
0.28 ± 0.04 0.54 ± 0.07* 0.41 ± 0.06 0.28 ± 0.04 0.21 ± 0.02 0.14 ± 0.04
Values represent mean ± SEM. Mitochondrial ATP production rates are mmol ATP/mmol acetyl-CoA/min (at 25 C) and pyruvate dehydrogenase complex activity is mmol
acetyl-CoA/min/kg wet muscle (at 37 C). Significant difference between corresponding time-points between patients with pancreatic cancer and patients with benign
disease: *p < 0.05; ***p < 0.001.
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mitochondrial substrates (Fig. 2, all p < 0.05). There was no impact
of surgery on succinate-derived mitochondrial ATP production
(Fig. 2).
Table 1 illustrates that MAPR for the substrate combination of
glutamate and succinate were greater in patients with cancer pre-
(p < 0.001) and post-surgery (p < 0.05) when compared with those
with benign disease. No other difference was found when
comparing the two patient groups.4. Discussion
This study aimed to assess the impact of major abdominal sur-
gery on PDC activity and mitochondrial function in a large muscle
group (VL) distant to the site of surgical trauma. The findings
demonstrate clear and comprehensive declines in muscle PDCFig. 2. Maximal mitochondrial ATP production rates in vastus lateralis muscle pre and
post major abdominal surgery. Maximal ATP production rates were determined uti-
lizing the substrate combinations depicted on the X-axis. Values represent
mean ± SEM and individual values. Differences between pre- and post-surgery:
*p < 0.05.activity and mitochondrial MAPR that occurred from pre- to post-
surgery, and in the absence of changes in muscle glycogen and
lactate contents and proteins reflecting muscle inflammation, at-
rophy and impaired carbohydrate oxidation.
We have previously demonstrated that inflammation-mediated
impairment of PDC plays an important role in the acute (within 2 h)
dysregulation of muscle metabolism in an animal model of endo-
toxemia [5], and in patients within 6e8 h of admission to the
intensive care unit [6]. Consistent with these observations, we [2]
and others have also shown that inflammation local to the site of
surgery plays an important role in the comprehensive dysregula-
tion of muscle metabolism in surgical patients [22e24]. Other
studies have also reported that cytokines influence skeletal muscle
catabolism both directly by modulating protein synthesis and
degradation and indirectly, through inhibition of the regulatory
action of anabolic hormones [25] and activation of the
hypothalamic-pituitary-adrenal axis [26].
The present study focused on the VLmuscle distant to the site of
surgical trauma, in which there was limited evidence of inflam-
mation or changes in protein or fuel metabolism apart from mRNA
changes [2]. However, with the exception of succinate, which feeds
into complex II of the electron transport chain (ETC), major declines
in MAPR for all substrate combinations employed that feed into
complex I were observed in the same muscle sample immediately
following surgery. Malate, along with pyruvate, generates oxalo-
acetate, and subsequently citrate via the tricarboxylic acid (TCA)
cycle. Acetyl-CoA from pyruvate and palmitate derived acyl-CoA
also generates citrate, whilst glutamate is utilized to generate a-
ketoglutarate, another component of the TCA cycle. Collectively,
these substrates produce the necessary TCA cycle intermediates for
NADH production that feeds into complex I of the ETC. Further-
more, the increased availability of these intermediates shifts the
dynamic equilibrium of the TCA cycle, essentially blunting succi-
nate conversion to fumarate and the production of FADH2 by the
TCA cycle, which diminishes the donation of electrons to complex II
of the electron transport chain. Overall, therefore, the data depicted
in Fig. 2 clearly suggest that the declines in MAPR observed as a
result of major abdominal surgery were focused on pathways that
feed electrons into complex I of the ETC. This observation is also in
keeping with the reduction in PDC activity observed following
surgery (Fig. 1). Furthermore, the declines in MAPR cannot be
attributed to any reduction in the mitochondrial content given
citrate synthase activity was unchanged from pre- to post-surgery.
In the absence of vigorous evidence of muscle inflammation,
what might then explain the comprehensive changes in VL muscle
PDC activity and mitochondrial MAPR that occurred from pre- to
post-surgery? Changes in systemic insulin and fuel substrate
R. Atkins et al. / Clinical Nutrition 40 (2021) 1046e10511050availability are known to alter PDC activity and mitochondrial fuel
oxidation [27,28], but neither plasma insulin or free fatty acid
concentrations were found to change appreciably from pre- to
post-surgery [2]. Furthermore, neither would explain the sup-
pression of MAPR seen in the present study. More compelling is the
evidence that general anesthetics and muscle relaxants have been
reported to impair mitochondrial function in human cell culture
[17] and animal models [29]. Furthermore, of particular relevance
to the current findings halogenated anesthetics [11,13e15], barbi-
turates [12] and propofol [16,17] have been reported to inhibit
oxidation of substrates entering at mitochondrial complex I level,
and were included in the standard list of drugs used for anesthesia
in the current study (Table 2). Animal-based drug intervention
models tend to be pharmacological rather than physiological in
nature and it is, therefore, of importance to note that Miro et al. [18]
reported a common decrease in isolated mitochondrial respiratory
capacity in skeletal muscle obtained during general anesthesia in
patients undergoing hip prosthesis placement or femoral fracture
repair when comparedwith those undergoing the same procedures
under regional anesthesia. Furthermore, these events were not be
explained by inhibition of ETC complex activity or uncoupling of
oxidative phosphorylation [18]. Whilst in agreement with the
findings of the present study, the authors [18] did not collect pre-
and post-surgery muscle biopsy samples nor did they determine
tissue inflammatory status, which was likely to have been marked
since muscle was obtained from the quadriceps muscle group
during hip or femur related surgery. Therefore, a definitive
conclusion about the relative contribution of surgical trauma-
related inflammation and general anesthesia to the decline in
mitochondrial respiration observed was not possible. We
acknowledge that because pre- and post-surgerymuscle biopsies in
the present study were obtained whilst patients were anesthetized
we cannot be definitive about the relative contributions of surgical
trauma and general anesthesia to the decline in mitochondrial
function reported herein. However, muscle biopsies were obtained
as soon as possible following the start of induction of anesethesia
(45e65 min), and given there was no evidence of a substantive
inflammatory response in the VL during surgery [2], it does seem
reasonable to conclude that general anesthesia was also a
contributor to the mitochondrial dysfunction observed.
In conclusion, the results of the present study demonstrate that
during major elective abdominal surgery PDC activity and MAPR
are acutely impaired in VL muscle distant from the site of surgical
trauma. Furthermore, these events occurred under conditions
where pre- to post-surgery changes in systemic insulin and free
fatty acid concentrations, muscle glycogen and lactate contents and
the expression of proteins reflecting muscle inflammation, atrophy
and impaired carbohydrate oxidation were absent, but muscleTable 2















Desflurane or sevofluranemRNAs were differentially expressed. These findings further the
understanding of the acute dysregulation of mitochondrial function
in muscle distant to the site of major surgical trauma in patients,
and point to the combination of general anesthesia and trauma-
related inflammation as being drivers of muscle metabolic insult
that warrants further investigation.Funding
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